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Abstract
Background: Preterm birth (PTB), birth at <37 weeks of gestation, is a significant global public health problem.
World-wide, about 15 million babies are born preterm each year resulting in more than a million deaths of children.
Preterm neonates are more prone to problems and need intensive care hospitalization. Health issues may persist
through early adulthood and even be carried on to the next generation. Majority (70 %) of PTBs are spontaneous
with about a half without any apparent cause and the other half associated with a number of risk factors. Genetic
factors are one of the significant risks for PTB. The focus of this review is on single nucleotide gene polymorphisms
(SNPs) that are reported to be associated with PTB.
Results: A comprehensive evaluation of studies on SNPs known to confer potential risk of PTB was done by
performing a targeted PubMed search for the years 2007–2015 and systematically reviewing all relevant studies.
Evaluation of 92 studies identified 119 candidate genes with SNPs that had potential association with PTB.
The genes were associated with functions of a wide spectrum of tissue and cell types such as endocrine,
tissue remodeling, vascular, metabolic, and immune and inflammatory systems.
Conclusions: A number of potential functional candidate gene variants have been reported that predispose
women for PTB. Understanding the complex genomic landscape of PTB needs high-throughput genome
sequencing methods such as whole-exome sequencing and whole-genome sequencing approaches that will
significantly enhance the understanding of PTB. Identification of high risk women, avoidance of possible risk factors,
and provision of personalized health care are important to manage PTB.
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Background
Preterm birth (PTB) is defined by the World Health
Organization (WHO) as the birth of a baby before the
completion of 37 weeks of gestation [1]. Global estimates
for 2012 have revealed PTB to be one of the two top causes
of child mortality second only to pneumonia and account-
ing for more than a million deaths each year [2, 3]. PTB is
a worldwide significant clinical and public health problem.
Data based on 2010 national estimates of 184 countries
has shown 11 % (range 5–18 %) prevalence of PTB result-
ing in 15 million preterm babies [4]. Majority of PTBs
(60 %) occur in Africa and South Asia, however, rich and
industrially advanced countries also share the problem
with a prevalence of about 6–7 %. Among the rich nations,
the United States has the highest (10 %) prevalence. Recent
data [4] for top 10 countries with highest number of PTBs
(Table 1) and with highest rates of PTB per 100 live births
(Table 2) are shown. In addition to the short term or
immediate implications during the first month of neonatal
life, PTB has long term lifelong consequences for the
premature babies, their families, and for the overall popula-
tion. Global Burden of Disease estimates show that PTB
accounts for 3.1 % of all Disability Adjusted Life Years,
more than that for HIV and malaria [5, 6]. Preterm neo-
nates are many times more prone to problems including
low blood sugar, jaundice, sepsis, pulmonary dysfunction,
ophthalmological disorders, and long-term neurocognitive
deficits [7, 8]. The frequent need for intensive care hospi-
talizations is associated with enormous emotional and
financial burden. Estimates for the United States show that
preterm-related death constitutes about 35 % of all infant
deaths and preterm complications cost more than $26
billion (may even be $50 billion according to other
estimates that include long term costs) to the U.S. health
services [9]. Recent studies have found PTB infants to be
at a long term disadvantage and even at increased risk of
mortality during early adult years [10]. Not only were the
PTB infants more likely to die in early childhood but also
were more prone to mortality at 18–36 years of age due to
cardiovascular, endocrine, and respiratory problems [10].
Even late preterm babies born at 34–36 weeks gestation
were at higher risk compared to the term birth babies
(37–42 weeks). The repercussions of PTB can even be felt
in the subsequent generations as PTB individuals are less
likely to reproduce [11]. Women who were born preterm
have increased chances of having PTB thus continuing the
vicious cycle of neonatal mortality and morbidity.
According to the severity of the shortened gestation,
PTBs are subdivided into extremely preterm (less than
28 weeks) constituting about 5 % preterm births, severe
or very preterm (28–31 weeks) constituting about 15 %,
moderate preterm (32–33 weeks) constituting about
20 % while the majority (60 to 70 %) are late preterm or
near term births (34–36 weeks) [4, 8]. A representative
distribution of PTBs for singleton pregnancies in the
United States for 2013 is presented in Table 3 (as an ex-
ample of a country with complete birth record informa-
tion). Of all the preterm births, about 70 % are
spontaneous PTBs including 45 % that occur as a result
of preterm labor and additional 25–30 % that occur as a
result of preterm premature rupture of membranes
(PPROM). The remaining about 30 % preterm births are
Table 1 Top 10 countries with greatest number of preterm
birth (PTB) in 2010a
Name of the country Number of PTBs




India 3519100 (23.6) 13.0
China 1172300 (7.8) 7.1
Nigeria 773600 (5.2) 12.2
Pakistan 748100 (5.0) 15.8
Indonesia 675700 (4.5) 15.5
The United States of America 517400 (3.5) 12.0
Bangladesh 424100 (2.8) 14.0
The Philippines 348900 (2.3) 14.9
The Democratic republic of
Congo
341400 (2.3) 11.9
Brazil 279300 (1.9) 9.2
aAdapted from [4]
Table 2 The 10 countries with the highest rates of preterm
birth (PTB) per 100 live births in 2010a












Table 3 Distribution of preterm births (PTB) for singleton







Extremely preterm <28 0.58 5.9
Severe or very preterm 28–31 0.96 9.9
Moderately preterm 32–33 1.18 12.2
Late preterm or near term 34–36 6.99 72.0
aAdapted from United States National Vital Statistics Reports 2015 [132]
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due to an obstetrician’s decision to induce preterm deliv-
ery of the baby because of adverse and deteriorating
uterine environment [8].
In view of the importance and urgency of the problem
of PTB, the Institute of Medicine (IOM) [9] under the
aegis of the National Research Council of the United
States convened the Committee on “Understanding
Premature Birth and Assuring Healthy Outcomes” in
2007. The goals of the committee were to address the up-
to-date status of science and clinical research of PTB,
asses the health and financial impact of the problem of
the PTB, and suggest a framework of recommendations to
prevent and minimize the debilitating burden of the prob-
lem. The deliberations of the committee resulted in an
exhaustive report on the PTB in 2007 [9] with up-to-date
review of literature, assessment and recommendations. In
addition to this exhaustive report there have been several
reviews on the problem of PTB [2, 4, 12, 13] published
recently. The number of studies on genetic polymorphism
in relation to PTB has dramatically multiplied since the
IOM report. However, the information about these genetic
polymorphisms is dispersed and not available on a single
platform. The purpose of the current review was to
discuss and tabulate all recent studies on genetic polymor-
phisms associated with potential risk for PTB that have
been published since the IOM report of 2007. A compre-
hensive literature search was done on preterm birth and
SNPs in PubMed (www.ncbi.nlm.nih.gov/pubmed/). The
terms used for searching the database were: preterm birth,
PTB, premature birth, preterm premature rupture of
membranes, PPROM, premature rupture of membranes,
PROM, pregnancy outcome, single nucleotide polymorph-
ism, SNP, gene variants, gene polymorphism, and genom-
ics of preterm birth. The search was restricted to years
2007 to 2015 and search terms were used in combination
to maximize the retrieval of relevant articles and for
exclusion of unrelated literature. The reference lists of the
included research articles were further scanned for identi-
fication of additional topic-relevant research articles. The
initial search resulted in identification of about 300 journal
articles. The titles of these articles were preliminarily
scanned for relevance to the topic of preterm birth and
genomics. Irrelevant articles, case reports, and editorials
were excluded. Finally, 92 journal articles on association
of preterm birth and single nucleotide polymorphisms
were deemed relevant and included in this review.
Risk factors associated with PTB
Many factors have been attributed to increase the risk of
PTB. These factors have been reviewed in several reports
previously [8, 9, 12, 13]. The risk factors can be broadly
grouped into following major categories with a brief intro-
duction for each category and are illustrated in Fig. 1.
Behavioral and sociodemographic factors
This category represents most of the maternal demographic
risk factors including socio-economic status, race, age,
marital status and educational level. Women belonging to
African ethnicity have a higher risk of PTB. Women with
low socio-economic status, lower age, lower educational
level, or are unmarried have higher risk of PTB. Social
behaviors such as smoking, drinking, illicit drug use, and
other risky social activities also increase the predilection for
PTB. Nutritional deficiencies such as vitamin D, folic acid,
and iron deficiency as well as low prenatal body weight or
obesity are risk indicators for PTB. Women who suffer
from anxiety, depression or have stressful work environ-
ment are also at increased risk of PTB. Physical or sexual
abuse or inadequate social support also puts pregnant
women at the risk of PTB. More information on behavioral
and sociodemographic factors is available in recent reviews
[8, 9, 12, 13].
Medical and pregnancy conditions
Multiple gestations, previous history of PTB, or short inter-
pregnancy interval are risk factors for PTB. About 40 % twin
pregnancies have gestation length of less than 37 weeks and
almost all of the higher multiple gestations end in PTB. A
prior history of PTB increase the risk of next delivery by 2.5
folds. Uterine distension or vaginal bleeding are also risk
factors for the PTB. Medical disorders such as hypertension,
diabetes, and thyroid problems in pregnant women also
increase the risk for PTB. Cervical shortening or cervical in-
sufficiency due to trauma or malformations also increase the
risk of PTB. Medical and pregnancy conditions predisposing
for PTB have recently been reviewed in detail [8, 9, 12, 13].
Fig. 1 Risk factors associated with preterm birth
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Genetic factors
It has been increasingly evident that genetic factors play a
significant role in the etiology of PTB. Preterm birth has
tendency for familial aggregation. Women who were born
preterm have higher risk of PTB; furthermore, the risk of
PTB increases by 80 % in women with sisters who have
experienced PTB. Studies on interracial couples have
shown that women married to men of African American
ethnicity have higher prevalence of PTB. Several studies
have been done on the genetic association of single
nucleotide polymorphisms (SNPs) in candidate genes to
predict their association with PTB. The focus of this
review is the exhaustive list of genetic studies that have
been reported since 2007 and these will be discussed in
detail later in the paper. For details about genetic studies
before 2007, several reviews are available [8, 9, 12].
Environmental factors
Ever-increasing environmental pollutants and xenobiotics
are turning out to be additional important factors for PTB.
For example, bisphenol A, a plastic based environmental
pollutant has recently emerged as a risk factor for PTB. Air
pollution either by itself or through interaction of particu-
late matter with genetic polymorphisms has also been re-
ported to be a risk for PTB. Sulphur dioxide air pollution is
another environmental factor that has been associated with
PTB. Living in the vicinity of coal burning power plants in
Croatia was reported to increase the incidence of the PTB.
Women living in the vicinity of petroleum and petrochem-
ical industries and ship building industries in China also
experienced increased incidence of PTB. Several studies
have been done on agricultural pesticides and herbicides
and some of them have shown to increase the incidence of
PTB with others remaining equivocal. With increasing use
of computers and computer related products, and the
associated accumulation of waste pollutants in the
environment, the need is to be on the side of caution as
their effects on the outcome of pregnancy remain largely
unknown/unpredictable. The association of environmental
factors with PTB has been reviewed in detail [9].
Biological pathways
Common biological pathways that play important role in
the pathogenesis of PTB are infections and inflammation,
maternal-fetal hypothalamopituitary adrenal activation,
decidual defects, and pathological uterine overdistension.
PTB has multifactorial origins and often several systems
in the body and many different factor classifications inter-
act in increasing the risk of PTB. Microbial infections are
a major risk factor for PTB and this can be as a result of
systemic intrauterine or infections or lower genital tract
infections. According to some conservative estimates, mi-
crobial intrauterine infections account for about 25–40 %
of PTBs. The mechanism apparently is through innate
immunity activation that leads to interaction of toll-like
receptors, inflammatory cytokines, and chemokines.
Endotoxins lead to production of prostaglandins which
stimulate the uterine contractility resulting in premature
labor. Uteroplacental ischemia also leads to PTB. Several
studies have indicated that periodontal disease causes PTB
possibly due to heightened inflammatory state. More
information about biological pathways that predispose to
PTB is available in several recent reviews [8, 9, 12, 13].
Idiopathic factors
Preterm birth is a multifactorial syndrome and the exact
cause of the condition remains poorly defined. It is esti-
mated that only 50 % PTBs can be assigned to a known
risk or causative factor, while the rest remain idiopathic.
Genetic polymorphisms associated with PTB
The initial approach to identify genetic variants conferring
an increased risk for PTB was to select candidate genes
based on the functional association with a major system in
the pathway of PTB. Recently more and more studies are
non-candidate driven focusing on genome wide associ-
ation studies in which thousands of polymorphisms are
screened at once. In contrast to earlier methods in which
only few genetic regions of specific genes are investigated,
the genome wide association studies target the whole
genome. Genetic polymorphisms associated with PTB are
grouped under the following body systems for descriptive
purpose and genes are listed in Additional file 1: Table S1.
Endocrine system related gene polymorphisms
Human pregnancy is dependent on the coordinated synthe-
sis, secretion, and interplay of hormones among the fetus,
mother, and placenta. Childbirth also involves sequential
structural and functional changes in the uterus and cervix
effected by coordinated interplay of hormonal mechanisms
during the terminal stages of the pregnancy. During partur-
ition uterus changes from a state of quiescence and relax-
ation during pregnancy to a state of regular, recurring, and
synchronous contractions probably owing to removal of
mechanisms that promote uterine relaxation [14–16]. The
decrease in progesterone concentrations that occurs at the
time parturition is one of the examples of loss of quiescence
factors at the end of gestation. Decrease in progesterone is
simultaneously associated with up-regulation of gene
expression for the oxytocin receptor that plays a crucial role
in parturition [14, 17]. Progesterone treatment is commonly
and effectively used to prevent recurrences of preterm labor
[18]. Several studies have been done recently on the associ-
ation of polymorphisms in the progesterone receptor (PGR)
gene with PTB. However the results have been equivocal.
Ehn et al. [19] analyzed 17 SNPs of PGR gene in 415 PTB
families and identified significant associations were for both
the mother and the preterm baby [19]. Similarly, other
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studies reported PGR gene polymorphisms for minor allele
(G for rs471767 or rs1942836) in women with PTB [20,
21]. Furthermore, they were more likely to carry to
carry the GT haplotype across rs471767 and rs578029
compared to women with term pregnancy. Progesterone
receptor SNPs were also associated with beneficial or harm-
ful treatment-genotype interaction in African American,
Hispanic, and Caucasian women who received progester-
one caproate treatment for recurrent PTB prevention [22].
Several other studies, however, did not find any association
between PGR SNPs and PTB [23–25]. No genetic polymor-
phisms were also found in mitochondrial localization se-
quence of the truncated progesterone receptor (PR-M)
gene in a group of women at high risk for PTB [26].
Oxytocin (OXT) and its receptor (OXTR) are other
crucial hormone system involved in childbirth [27–29].
Oxytocin causes myometrial contractions and helps in
assisting cervical ripening [30, 31]. Oxytocin receptor gene
is expressed in myometrial and endometrial tissue and
also in many other tissues of the body including the
central nervous system [28]. To-date many SNPs (several
dozen) have been reported in the OXTR gene, however,
less is known about their association with physiological
processes. Recently some studies have reported associ-
ation of OXTR gene polymorphisms with PTB risk
[32–34]. An exhaustive study was done in 651 PTB infants
and their parents for analyses of 16 single nucleotide
polymorphisms (SNPs) in genes for OXT and OXTR, and
leucyl/cystinyl aminopeptidase (LNPEP) [35]. Two common
SNPs of OXTR (rs4686302, rs237902) were shown
apparently to be associated with PTB. Kuessel et al. [34]
studied four common OXTR polymorphisms (rs53576,
rs2254298, rs237911, rs2228485) in 100 women each with
PTB and term birth. Although no relationship was revealed
for each of the four individual polymorphisms and PTB,
however, the haplotype combination of rs2228485 C allele,
rs2254298 A allele, and rs237911 G allele was found to be
significantly associated with an increased risk of PTB.
Relaxin is an important hormone involved in softening
of pubic symphysis and collagen remodeling during
pregnancy [36]. Serum levels of relaxin are lower in early
pregnancy and higher during late pregnancy in women
with PTB compared to women with term birth [37].
Increased expression of intrauterine relaxin occurs in
women with PPROM [38]. Risk of PTB is high in
mothers having homozygosity of the rarer allele
(rs10115467 and rs4742076) in the relaxin 2 gene (RLN2
[39]). In a Filipino population, a SNP in RLN2 promoter
(rs4742076) was associated with the elevated decidual
RLN expression and PPROM, while as rs3758239 was
associated with both PPROM and PTB [40].
Polymorphisms in several other genes related to endo-
crine system have been reported to increase or decrease
the risk of PTB. In Finnish and African American mothers
SNPs in follicle stimulating hormone receptor (FSHR)
gene were associated with PTB [41, 42] and were
predicted to likely disrupt zinc finger E-box binding
homeobox 1 (ZEB1) and elongation factor 3 (ELF3)
transcription factor binding sites [42]. In Norwegian
population, a polymorphism in prostaglandin E receptor 3
gene (PTGER3; rs977214) in women exerted a protective
effect against PTB [43]. PTGER3 is a gene associated with
inflammatory response and plays a role in initiation of
labor. However, another study found an increased risk of
PTB in women with SNP in PTGER3 [44]. Polymorphisms
in prostaglandin D receptor (PTGDR) also increased the
risk of post-coital preterm birth in women [45]. Poly-
morphism in type 1 insulin-like growth factor receptor
(IGF1R) in fetus [46] and insulin-like growth factor bind-
ing protein 3 (IGFBP3) in mother [47] also increased the
risk of PTB. Polymorphisms in corticotropin-releasing
hormone receptor 2 gene (CRHR2) were not associated
with increased risk of PTB [48], but a linkage candidate
gene approach for identifying genetic variants playing role
in PTB found CRHR1 in infants associated with risk for
PTB [47]. The endocrine related genes associated with
PTB are listed in Additional file 1: Table S1.
Tissue remodeling and biogenesis related gene
polymorphisms
Many of the changes in molecular remodeling of the
tissues and myometrial contractions during parturition
are not yet known or fully characterized. Functional
genomic approach has been used during the last decade
to analyze gene expression in human [49–51] and rodent
myometrium [50, 52]. These studies revealed a number
of genes that might be important in the molecular
control of initiation of parturition. Comparison of
uterine tissue samples of pregnant women in labor and
before labor revealed differential expression of genes for
myometrial gap junction protein connexin-43 [53], es-
trogen and progesterone receptors [54], prostaglandin
endoperoxide synthase 1 and 2 (PTGS1 and PTGS2)
[55], intercellular adhesion molecule-1 (ICAM1) [56],
15-hydroxyprostaglandin dehydrogenase (HPGD) [57],
interleukin-8 (IL8) [58], and prostaglandin-endoperoxide
synthase 2 (PTGS2), and calgranulin B (S100A9) [17].
Recent studies have also shown that DNA variants in
genes involved in extracellular matrix metabolism such
as tissue inhibitor of metalloproteinase 2 (MMP-2) and
collagen type IV alpha-3 chain (COL4A3) were found to
increase the risk of PTB [32, 33]. Heat shock protein 47
(SERPINH1) which is involved in the maturation of
collagen molecules is enriched in African and African
American populations and has been found to be associ-
ated with PTB [12]. Polymorphism in genes like TIMP
metallopeptidase inhibitor 2 (TIMP2), COL1A2, and
endothelin 1 (EDN1) almost double the risk of PTB and
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both maternal and fetal DNA variants are associated
with spontaneous PTB [32, 33]. In African American
women, an analysis of 1500 SNPs resulted in identification
of a susceptibility locus on chromosome 7 which mediates
PTB. The locus contains many potential genes including
COL1A2 [22]. In another study [59], polymorphisms in
COL5A2 and COL5A1 were associated with spontaneous
PTB. In contrast, lysyl oxidase-like 1 (LOXL1) which is
involved in connective tissue biogenesis does not contrib-
ute significantly to risk of PTB or PPROM [60]. Similarly,
another study [61] also found no evidence of association
between spontaneous PTB and polymorphisms inMMP-1
(1607 1G/2G) and MMP-9 (1562 C/T) genes. The tissue
remodeling and biogenesis related genes associated with
PTB are listed in Additional file 1: Table S1.
Vascular and angiogenesis related gene polymorphisms
Uteroplacental ischemia or hemorrhage is one of the risk
factors of spontaneous PTB and bout 15 % PTBs are due to
impairment of placentation [62, 63]. Andraweera et al. [62]
studied 1190 nulliparous caucasian women and identified
that interactions of polymorphisms in vascular endothelial
factor A (VEGFA) and angiopoietin 1 (ANGPT1) with
maternal body mass index (BMI) were associated with
higher risk of PTB. Genes regulating renin-angiotensin
system have also been implicated in PTB. Angiotensinogen
(AGT) 174–235 region has been associated with PPROM
[64]. Uma et al. [65] demonstrated that polymorphisms in
angiotensin converting enzyme gene (ACE) in fetal geno-
type were associated with higher risk of PTB. Several other
studies reported that variants of the adrenergic receptor
beta 2 gene (ADRB2), inducible nitric oxide synthase
(NOS2A), thrombomodulin, endothelial nitric oxide syn-
thase (NOS3A), plasminogen activator inhibitor-2, and
alpha adducin (ADD1) were associated with PTB [66, 67].
Coagulation/thrombophilic pathway was predicted to influ-
ence the PTB and interestingly, the plasminogen activator
inhibitor-1 (SERPINE1) polymorphism was found to be
associated with PTB [68]. Genetic analysis of 542 women
with PTB and 1141 women with term deliveries identified
that Factor V (F5) gene SNPs interacted with maternal
smoking and increased the risk of PTB [69]. In contrast,
thrombophilic gene polymorphisms did not haveany associ-
ation with PTB [70]. Small conductance calcium-activated
potassium channel 3 (KCNN3) plays a role in smooth
muscle relaxation and arterial tone. Polymorphisms in
maternal KCNN3 gene (rs1218585, rs1218584, rs883319)
have been found to increase the risk PTB [21, 71]. The
vascular and angiogenesis related genes associated with
PTB are listed in Additional file 1: Table S1.
Metabolism related gene polymorphisms
The cytochrome P450 isoenzymes are involved in the
metabolism of organic molecules and the biosynthesis of
steroids, lipids, and vitamins. Steroid biosynthetic path-
way is an important pathway in the pregnancy mainten-
ance and embryonic development and survival. Source
of cholesterol in mother depends on the dietary intake
and synthesis within the body whereas that of the fetus
is dependent on the mother through placental circula-
tion [72]. Cholesterol is necessary for synthesis of steroid
hormones in the mother, placenta and the fetus. Large
amounts of maternal steroid hormones are metabolized
by the placenta in order to allow normal development of
the fetal organs and regulate the pregnancy. During
pregnancy the maternal blood lipid levels and mutations
in cholesterol metabolism are associated with a risk for
PTB [73–75]. Lanosterol 14α-demethylase (CYP51A1) is
a regulatory enzyme involved in later stage of cholesterol
biosynthesis. Analysis of CYP51A1 polymorphisms in
188 women with PTB and in 188 PTB infants suggested
new links between PTB and cholesterol synthesis.
Absence of a single allele for CYP51A1 in a preterm
infant/mother combination though with low frequency
conferred a risk for PTB [76]. In a separate study, fatty
acid metabolism pathway genes were reported to
exhibit modest association with PTB [77]. Polymor-
phisms in several cholesterol metabolism genes such as
7-dehydrocholesterol reductase (DHCR7), 3-hydroxy-3-
methyl-glutaryl-CoA reductase (HMGCR), apolipopro-
tein A-I (APOA1), and ATP-binding cassette trans-
porter (ABCA) in the mother and fetus were found to
increase the risk of PTB [74]. A linkage candidate gene
approach for identifying genetic variants playing role in
PTB found cytochrome P450 2E1 (CYP2E1) in infants
and ectonucleotide pyrophosphatase /phosphodiester-
ase family member 1 (ENPP1) and DHCR7 in mothers
associated with PTB [47].
Glutathione S-transferase μ 1 (GSTM1) enzymes are in-
volved in xenobiotic metabolism that includes detoxifica-
tion of electrophilic compounds such as environmental
toxins, therapeutic drugs, carcinogens, and products of
oxidative stress. In Korean women, gene-environment
(particulate matter) interaction study between the GSTM1
null genotype conferred a higher risk of PTB [78]. Lee et
al. [79] reported that GSTM1 null genotype confers risk of
PTB independent of serum paraoxonase/arylesterase 1
(PON1) genotype in Korean pregnant women. PON1
causes hydrolysis of the organophosphorus compounds
and it was found that a fetus with the susceptible PON1
(-108TT) genotype was at higher risk of PTB [80]. In 434
Norwegian mother-baby diads, the most significant associ-
ation with PTB was for a polymorphisms in fetal PON1
[43]. Interaction of organochlorine pesticides with SNPs
in CYP1A1m2 and GSTM1 null genotypes may magnify
the risk of PTD [81]. An analysis on 1030 African
American mothers for African ancestry characters and
polymorphisms in CYP1A1 and glutathione S-transferase
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theta-1 (GSTT1) in relation to pregnancy outcome
revealed significant contributions of African ancestry and
CYP1A1- and GSTT1-smoking interactions to PTB [82].
Similarly, maternal CYP1A1 heterozygous mutation and
homozygous mutation in combination with GSTT1 null
genotypes confers the risk of PTB [83]. Association of
GSTT1/GSTT2 and P4501A1 with PTB was also reported
in other studies [84, 85] suggesting that the combined
genotypes of CYP1A1 and GSTT1/GSTT2 help identifica-
tion of pregnant women who are at higher risk of spon-
taneous PTD owing to passive smoking.
Polymorphisms in C-1-tetrahydrofolate synthase (MT
HFD1), which is involved in folate metabolism did not
show any association with PTB [86, 87]. However, serine
hydroxymethyltransferase (SHMT) enzyme that plays a
role in folate metabolism was associated with PTB [88].
Other recently identified gene polymorphisms associated
with PTB include peroxisome proliferator-activated recep-
tor gamma (PPARG) [89] and FokI vitamin D receptor
(VDR) [90]. The metabolism related genes associated with
PTB are listed in Additional file 1: Table S1.
Innate immunity and inflammation related gene
polymorphisms
Immune and inflammatory related gene polymorphisms
are by far the most studied polymorphisms in relation to
spontaneous PTB. Independent reviews focusing solely
on the inflammatory related genetic risk factors targeting
years until 2009 are available [91, 92].
Inflammation and immunity processes are a multi-
pronged biological reaction of the body tissues to harmful
pathogens and involves cellular and humoral responses.
Cytokines, antibacterial proteins, and antibodies synthe-
sized and secreted in the body protect against the infec-
tions. Genetic polymorphisms regulating the maternal
immunologic response during pregnancy may cause an in-
sufficient or exaggerated inflammatory response to micro-
bial infections and lead to an increased risk of preterm
birth. Interleukins are cytokines involved in inflammatory
response and IL1 modulates inflammatory responses
through integrins on leukocytes and endothelial cells.
Polymorphisms in the IL1α gene in Japanese women were
associated with PTB [93] but IL1β polymorphism with or
without bacterial vaginosis did not confer any increased
risk for PTB [94]. IL1β is a proinflammatory cytokine and
an important mediator of innate immune response to
microbial products. In a Brazilian population with known
high rate of PTB, mothers carrying polymorphisms in
intron 2 of IL1 receptor antagonist (IL1RN) gene were
found to have increased susceptibility to PTB [95]. IL1
receptor antagonist binds to IL1 receptor 1 (IL1R1) and
inhibits the association of IL1R1with the coreceptor for
signaling thus blocking the IL1 activity. Also, maternal
carriers of IL1RN polymorphism in a group of Polish
women were at increased risk of PTB and this risk was
further elevated with a coincidence of at least one copy of
IL6 allele G [96]. In non-Hispanic white women, higher
risk of PTB was found when both mother and child
carried the IL1RN intron2 repeat [97]. Interleukin 6 is a
proinflammtory cytokine released by T-cells and macro-
phages and stimulates inflammatory response during
infection. Studies on European Americans and African
Americans found potential role of polymorphisms of IL6
and IL6 receptor (IL6R) genes in PTB and in the differen-
tial disparity for the risk in the two ethnicities [98].
Genetic variations in IL6 and IL6R were found to be asso-
ciated with increased amniotic concentration of IL6 in
PTB patients [99].
Periodontitis was suggested to be associated with PTB
but a study on Japanese women did not find any associ-
ation between PTB and periodontitis [100]. However, poly-
morphisms in Fc fragment of IgA receptor (FCAR) and IL6
increased the risk for PTB in the same study. In contrast,
other studies [101, 102] have found no association of
polymorphism in IL6 and IL10 with PTB. Interleukin 10 is
an anti-inflammatory cytokine and attenuates the inflam-
matory response through effects on proinflammatory cyto-
kines and reduces the function of host immune cells, such
as neutrophils and macrophages. Polymorphism in genes
for Protein kinase C alpha (PRKCα) and IL6 interact with
bacterial vaginosis and confer increased risk for PTB [103].
An exhaustive study on 402 PTB mother-fetus combina-
tions and 1227 term mother-fetus combinations for
analysis of 775 SNPs in 190 candidate genes found that
IL6R1, involved in controlling fetal inflammation, doubled
the risk for PTB [33]. In contrast, maternal carrier of poly-
morphic alleles of IL1β (+3953C >T), IL6 (-174G > C), and
IL1RN genes did not show any association with PTB due
to PPROM [104]. In African American population, an
ethnic group with a known higher rate of PTB, polymor-
phisms in infection and inflammation related genes
particularly IL12 and IL12 receptor beta (IL12Rβ) were
found to confer elevated risk for PTB [105]. Similarly,
haplotypes of IL13/IL4 in a German population were also
associated with PTB [106].
Tumor necrosis factor (TNF) α is secreted by immuno-
competent cells after contact with microbial metabolites
and mediates the immunologic response of the host.
TNFα shows significant variability among individuals
possibly due to the genetic polymorphisms. Studies have
shown that polymorphisms in TNFα promoter confer an
increased risk of PTB [94, 107]. In Chinese Han popula-
tion polymorphisms in TNF receptor (TNFR2) gene did
not increase the risk of PTB but 96 TG (GG) genotype
may contribute to susceptibility to chorioamnionitis in the
process of PTB [108]. The increased risk of PTB in Danish
Caucasian women in association with polymorphisms of
TNFα and IL1β was attributed to dysregulation of the
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immune system in pregnancy [109]. Moura et al. [92] re-
ported that polymorphisms in TNFα, interferon (IFN)γ,
and IL6 were associated with elevated risk of PTB. TNFα
gene polymorphism G308A was associated with PTB and
the risk of PTB was reduced if mother's or child's geno-
type was G/A [110]. In several other studies TNFα gene
polymorphisms were consistently associated with PTB
[111–113]. Among African-American women, chances of
PTB were found to be higher if both mother and child car-
ried the TNFR2 M196R allele [97]. Polymorphisms in TNFα
also interacted with HEV infection during pregnancy and
increased the risk of PTB [114]. In contrast, other studies
did not find any association of TNFα -G308A mutation
with the risk of PTB [115] or PTB due to PPROM [104]. A
linkage candidate gene approach for identifying genetic var-
iants playing role in PTB found TNF receptor-associated
factor 2 (TRAF2) gene variants in mothers associated with
PTB [47].
Toll-like receptors (TLRs) are proteins involved in innate
immune response and are expressed in macrophages and
dendritic cells. Toll-like receptors interact with invading
microbes and activate immune cell response triggering pro-
duction of cytokines and chemokines. Polymorphisms in
TLR 2 variant confers increased risk of PTB [116]. Similarly,
fetuses that carry the Asp299Gly substitution in TLR4 con-
ferred an increased risk of PTB [117]. A study in German
population suggested an elevated risk of PTB with haplo-
types of IL4, IL13, and TLR10 [106]. In contrast, maternal
carriage of TLR4 1196 T allele may be associated with
reduced risk of PTB before 33rd week of gestation in Polish
population [118]. Polymorphisms in TLR pathway adapter
variant TIR domain receptor-associated protein (TIRAP)
have been found to render protection against PTB [119].
Polymorphisms in ICAM1 have also been found to
confer risk for PTB in a Korean population [120]. ICAM1
has a proinflammatory role in facilitating leukocyte
endothelial transmigration by signaling through cascades
involving a number of kinases. Polymorphisms in low
affinity immunoglobulin gamma Fc region receptor II-b
(FCGR2B) gene which is involved in regulation of anti-
body production and apoptosis also confer a higher risk
for PTB [121]. Gene-environment interactions of poly-
morphisms for protein kinase C alpha (PRKCα), fms-like
tyrosine kinase (FLT1), and IL6 with bacterial vaginosis
contributed to the risk of PTB [103].
Several other studies recently have reported the ass-
ociation of polymorphisms for many other immune and
inflammatory genes with PTB. These studies include the
genes such as defensin α 5 (DEFA5) [32, 33], IL1β [122],
major histocompatibility complex, class II, DQ alpha 1
(HLA-DQA1) [123], compliment region 1 (CR1) [124],
selenoprotein (SEPS1) [125], surfactant pulmonary-
associated protein D (SFTPD) [126], colony-stimulating
factor 2 (CSF2) [127], interferon γ receptor 2 (IFNGR2)
[127], and killer cell immunoglobulin-like receptor three
domain long cytoplasmic tail 2 (KIR3DL2) [127]. The full
list of the genes that have been reported with a potential
association with PTB is presented in Additional file 1:
Table S1.
Miscellaneous gene polymorphisms
Miscellaneous section contains information on genetic
polymorphisms that could not be included in any other
section and the number of studies was too small to
create separate sections for them. Analysis of nonsynon-
ymous mitochondrial DNA (mtDNA) variants A4917G,
G10398A and T4216C for potential interaction with
smoking and association with PTB was done in 422
pregnant Caucasian women [99]. Mitochondrial DNA
variants A4917G and T4216C conferred risk for PTB after
adjusting for smoking, indicating that mitochondrial
genome polymorphisms may play a significant role in PTB
through an interaction with smoking. In contrast, no
mitochondrial gene variant was found to contribute to the
maternal transmission of PTD in another study [128]. In
an African American population, polymorphisms in fetal
catechol-o-methyltransferase (COMT) gene (rs4818) con-
ferred increased risk of PTB [129]. Several signaling factors
such as early growth response 1 (EGR1), transcription
factor AP2A (TFAP2A), and specificity protein 3 (SP3)
have been suggested as useful in PTB risk prediction [130].
X-chromosomal SNPs data on a Norwegian, Danish and
Argentinean populations showed that the G allele of ma-
ternal SNP rs2747022 in the FERM domain containing 7
(FRMD7) gene conferred increased risk for PTB [131].
Conclusions
Preterm birth is increasingly being recognized as a
complex syndrome for which the etiology is not yet fully
understood. Lack of a well-defined etiology is a major
limitation in predicting impending spontaneous preterm
birth and instituting effective preventive measures. There-
fore, the challenge is to identify high risk women and
provide them a personalized medical care for reducing the
burden of PTB. In addition to infectious, lifestyle, and
demographic risks, genetic factors increasingly seem to be
important in PTB. Familial aggregation of PTB and
recurrent occurrence in women puts forth a case of
complex genetic predisposition. Study of genetic polymor-
phisms can be useful in predicting the risk for PTB. It has
been estimated that SNPs constitute about 90 % of all
genetic variations in the human genome. During the last
decade studies on functional candidate gene variants and
genome-wide linkage analyses in women and families
undergoing recurrent preterm birth have thrown forward
a large number of potential genes predisposing for
preterm birth. Majority of the significant associations for
SNPs and PTB are related to inflammation. Many of the
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polymorphisms exhibit inconsistency and remain incon-
clusive. Being a global problem preterm birth warrants
global solutions. Recent genomic approaches are begin-
ning to reveal the information for understanding the
causes of PTB. However, to fully appreciate and understand
the complexity of PTB, future approaches using high-
throughput genome sequencing methods such as whole-
exome sequencing and whole-genome sequencing studies
are essential. These may involve multicenter national and
international collaborative efforts and may also include
proteomic and metabolomics approaches that will signifi-
cantly enhance the understanding of PTB ultimately leading
to the formulation of preventive interventions.
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